GH Research PLC

GH Research PLC

World Rank (Jan-05-2024)
16,085
Market Cap (Jan-05-2024)
0.284 Billion USD
World Rank (Jul-30-2023)
10,432
Market Cap (Jul-30-2023)
0.732 Billion USD
World Rank (Jan-07-2022)
9,593
Market Cap (Jan-07-2022)
0.972 Billion USD
Headquarters Country
Ireland
Nasdaq / NYSE Code
GHRS
Market Cap (Mar-08-2026)
0.99
World Region
Europe
World Subregion
Northern Europe
Business Sector
Biotechnology
Biopharmaceutical
Company Website
GH RESEARCH PLC
Company Profile
GH Research PLC is a clinical stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The headquarters is in Ireland.
Founded Year
2018
IPO Year
2021
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share